While more than 18,000 cancer researchers are gathered in San Diego for the American Association for Cancer Research (AACR) meeting this week, we’re highlighting the most influential research articles in oncology in 2013 and a prestigious award for one of our Heads of Faculty. Prof. Bob Pinedo, Professor of Medical Oncology, Free University (VUMC) Amsterdam,…
In the second in our series of F1000Prime most influential articles we present the top-ranking articles in Critical Care & Emergency Medicine in 2013 and speak to a global influencer in the field. The top-ranking – clinical-practice changing – article, a randomized controlled trial, found that anesthesiologists should use a lung-protective ventilation strategy in intermediate-risk…
Today we’re introducing the first in a regular series of listings of the most influential papers in different areas of biology and medicine (F1000Prime Faculties). With the 21st International Molecular Medicine Tri-Conference (#tricon) taking place this month in San Francisco, we’re starting with articles published in the field of Molecular Medicine. This Top 10 comprises…
After F1000Prime published its 150,000th article recommendation last week, we reflect on some of the most influential biomedical articles of the last 3 years, as selected and rated by the F1000Prime Faculty. It’s almost 3 years exactly since we reached the milestone of 100,000 articles being recommended in F1000Prime. So, since January 2011, which articles…
“Again, they did it again! As with their other websites, it’s obvious that the F1000 crew puts a lot of thought into making F1000Trials an easy-to-use resource with a lot of helpful features. I’m sitting here clapping my hands,” said Donatas Zailskas, a 6th year medical Lithuanian student. But what do you think about F1000Trials?…
Faculty of 1000 today launches the beta version of a new service, F1000Trials, which is currently freely available to all registered users. In this post we explain the need for this new publishing service, what the key features are, and who should use it. Read the press release here. Are we at tipping point for…
At F1000, we are today announcing a new fully Open Access publishing program across biology and medicine, F1000 Research, which will launch later this year. It is intended to address the major issues afflicting scientific publishing today: timely dissemination of research, peer review, and sharing of data.
Many are quick to criticize the peer review process, but are there any viable alternatives?
With the volume of literature published in the biomedical sciences and the difficulty in keeping up to date with reading, what role do assumptions play in medicine?
Everybody’s at it. This time, it’s the turn of the venerable Company of Biologists—a Cambridge-based “non-profit organization whose objectives are the advancement and promotion of research in, and the study of, all branches of biology”. They publish a number of well-respected titles, including Development, Journal of Experimental Biology and one of my all-time favourites, the…
